Carlos Gómez-Navarro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Carlos Gómez-Navarro has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Adela Briones-Través
Servicio de Urgencias, Consorcio Hospital General Universitario de Valencia, Av. de les Tres Creus, 2, 46014 Valencia, Spain
2 shared publications- Eduardo Moreno-Escobar
Cardiology department. Hospital Universitario San Cecilio. Av. del Conocimiento , s/n, 18016 Granada
2 shared publications - Elena Sola-García
Inherited Cardiac Conditions & Myocardial Diseases Unit, Cardiology Department (J.M.S.-A., E.S.-G., I.J.-A., M.M.-I., A.B.G.-R., A.L.-E., J.A.U.-M.), University Hospital Jaen, Spain
2 shared publications - Felipe Fernández-Vázquez
Servicio de Cardiología, Hospital Universitario de León, Altos de nava, s/n, 24071 León, Spain
2 shared publications - Francisco José Bermúdez-Jiménez
Servicio de Cardiología, Hospital Universitario Virgen de las Nieves, Granada, Spain (F.J.B.-J.).
2 shared publications Francisco Sanz-Herrera
Servicio de Neumología, Consorcio Hospital General Universitario de Valencia, Av. de les Tres Creus, 2, 46014 Valencia, Spain
2 shared publications
Latest Publications
- 5 September 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (10) , 5325-5338
Effects of supervised exercise immediately after bariatric surgery: results from the EFIBAR randomized trial
Introduction Bariatric surgery is the most effective treatment for severe obesity. We evaluated whether a 16-week supervised exercise program initiated immediately post-surgery improves weight loss, body composition, cardiometabolic health, inflammation, and physical fitness compared with usual care. Methods In this randomized clinical trial, 80 participants undergoing bariatric surgery were assessed before surgery, 4- and 12-month post-surgery. The intervention consisted of 16 weeks of individually supervised concurrent exercise training initiated ~ 10 days post-surgery, with three 60-min sessions/week including progressive resistance training (50–75% of one-repetition maximum) and aerobic training (65–85% heart rate reserve). Adherence was monitored throughout the intervention. The main outcome was percent of total weight loss (%TWL). Results No significant differences between groups were observed for the primary outcome. At 4 months, %TWL was 24.9% in the exercise group and 23.4% in the control group; corresponding values at 12 months were 37.0% and 37.2%, respectively. Compared with usual care, the exercise group showed greater reductions in systolic blood pressure (− 6.5 mmHg; 95% CI, − 12.7 to − 0.2; p = 0.040) and glycated hemoglobin (− 0.3%; 95% CI, − 0.5 to − 0.1; p = 0.018) at 4 months. These differences were not maintained at 12 months. No significant between-group differences were observed in body composition, inflammatory markers, or physical fitness outcomes at any timepoint. Conclusion A 16-week supervised concurrent exercise program initiated ~ 10 days after bariatric surgery did not improve weight loss compared with usual care. Although short-term improvements in systolic blood pressure and glycated hemoglobin were observed, these were not sustained at 12 months.
- 5 September 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (10) , 5325-5338
Effects of supervised exercise immediately after bariatric surgery: results from the EFIBAR randomized trial
Introduction Bariatric surgery is the most effective treatment for severe obesity. We evaluated whether a 16-week supervised exercise program initiated immediately post-surgery improves weight loss, body composition, cardiometabolic health, inflammation, and physical fitness compared with usual care. Methods In this randomized clinical trial, 80 participants undergoing bariatric surgery were assessed before surgery, 4- and 12-month post-surgery. The intervention consisted of 16 weeks of individually supervised concurrent exercise training initiated ~ 10 days post-surgery, with three 60-min sessions/week including progressive resistance training (50–75% of one-repetition maximum) and aerobic training (65–85% heart rate reserve). Adherence was monitored throughout the intervention. The main outcome was percent of total weight loss (%TWL). Results No significant differences between groups were observed for the primary outcome. At 4 months, %TWL was 24.9% in the exercise group and 23.4% in the control group; corresponding values at 12 months were 37.0% and 37.2%, respectively. Compared with usual care, the exercise group showed greater reductions in systolic blood pressure (− 6.5 mmHg; 95% CI, − 12.7 to − 0.2; p = 0.040) and glycated hemoglobin (− 0.3%; 95% CI, − 0.5 to − 0.1; p = 0.018) at 4 months. These differences were not maintained at 12 months. No significant between-group differences were observed in body composition, inflammatory markers, or physical fitness outcomes at any timepoint. Conclusion A 16-week supervised concurrent exercise program initiated ~ 10 days after bariatric surgery did not improve weight loss compared with usual care. Although short-term improvements in systolic blood pressure and glycated hemoglobin were observed, these were not sustained at 12 months.
- 22 June 2022
- Published by Elsevier in Medicina Clínica (English Edition)
- Vol. 158 (12) , 569-575
Prevalence of bleeding secondary to anticoagulation and mortality in patients with atrial fibrillation admitted with SARS-CoV-2 infection
- 22 June 2022
- Published by Elsevier in Medicina Clínica (English Edition)
- Vol. 158 (12) , 569-575
Prevalence of bleeding secondary to anticoagulation and mortality in patients with atrial fibrillation admitted with SARS-CoV-2 infection
- 1 June 2022
- Published by Elsevier in Medicina Clinica
- Vol. 158 (12) , 569-575
Prevalence of bleeding secondary to anticoagulation and mortality in patients with atrial fibrillation admitted with SARS-CoV-2 infection
- 1 June 2022
- Published by Elsevier in Medicina Clinica
- Vol. 158 (12) , 569-575
Prevalence of bleeding secondary to anticoagulation and mortality in patients with atrial fibrillation admitted with SARS-CoV-2 infection